Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

October 31, 2008

Conditions
Dry Eye
Interventions
DRUG

0.05% cyclosporin eye drop

bid dosage for 4 months

Trial Locations (2)

10330

ACTIVE_NOT_RECRUITING

OPD Chulalongkorn University Hospital, Bangkok

Unknown

RECRUITING

OPD Chulalongkorn University Hospital, Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Chulalongkorn University

OTHER